NCLN
BOS complex subunit NCLN
Also known as: NCLN_HUMAN, NET59, NICALIN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q969V3
- Gene
- NCLN
- Ensembl
- ENSG00000125912
- Chromosome
- 19
- Canonical length
- 563 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm,Lipid droplets
OverviewNCBI Gene
Enables ribosome binding activity. Involved in several processes, including multi-pass transmembrane protein insertion into ER membrane; protein stabilization; and regulation of protein complex stability. Located in endoplasmic reticulum membrane. Part of multi-pass translocon complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
563 residues, UniProt reviewed canonical sequence.
>Q969V3|NCLN
1 MLEEAGEVLE NMLKASCLPL GFIVFLPAVL LLVAPPLPAA DAAHEFTVYR MQQYDLQGQP
61 YGTRNAVLNT EARTMAAEVL SRRCVLMRLL DFSYEQYQKA LRQSAGAVVI ILPRAMAAVP
121 QDVVRQFMEI EPEMLAMETA VPVYFAVEDE ALLSIYKQTQ AASASQGSAS AAEVLLRTAT
181 ANGFQMVTSG VQSKAVSDWL IASVEGRLTG LGGEDLPTIV IVAHYDAFGV APWLSLGADS
241 NGSGVSVLLE LARLFSRLYT YKRTHAAYNL LFFASGGGKF NYQGTKRWLE DNLDHTDSSL
301 LQDNVAFVLC LDTVGRGSSL HLHVSKPPRE GTLQHAFLRE LETVAAHQFP EVRFSMVHKR
361 INLAEDVLAW EHERFAIRRL PAFTLSHLES HRDGQRSSIM DVRSRVDSKT LTRNTRIIAE
421 ALTRVIYNLT EKGTPPDMPV FTEQMQIQQE QLDSVMDWLT NQPRAAQLVD KDSTFLSTLE
481 HHLSRYLKDV KQHHVKADKR DPEFVFYDQL KQVMNAYRVK PAVFDLLLAV GIAAYLGMAY
541 VAVQHFSLLY KTVQRLLVKA KTQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NCLN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 60 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 60 nTPM
- liver: 55 nTPM
- pancreas: 52 nTPM
- spleen: 41 nTPM
- cerebellum: 39 nTPM
- colon: 35 nTPM
Single-cell type
- late spermatids: 82 nCPM
- alveolar cells type 1: 79 nCPM
- colonocytes: 78 nCPM
- enterocytes: 75 nCPM
- enteric transient amplifying cells: 72 nCPM
- extravillous trophoblasts: 65 nCPM
Immune cell
- plasmacytoid DC: 19 nTPM
- classical monocyte: 13 nTPM
- intermediate monocyte: 13 nTPM
- eosinophil: 9.8 nTPM
- total PBMC: 9.6 nTPM
- myeloid DC: 9.2 nTPM
Brain region
- hippocampal formation: 40 nTPM
- cerebral cortex: 39 nTPM
- thalamus: 39 nTPM
- medulla oblongata: 36 nTPM
- amygdala: 35 nTPM
- midbrain: 34 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NCLN.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 108 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.4
- gnomAD pLI
- 0.76
- gnomAD missense Z
- 1.66
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- determination of left/right asymmetry in lateral mesoderm
- multi-pass transmembrane protein insertion into ER membrane
- negative regulation of nodal signaling pathway
- protein stabilization
- regulation of protein complex stability
- regulation of protein-containing complex assembly
- regulation of signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NCLN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NCLN as an antibody target. Whether an autoantibody or antibody against NCLN could matter depends on whether native NCLN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NCLN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NCLN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...